Cinnamaldehyde Improves Lifespan and Healthspan in Drosophila melanogaster Models for Alzheimer’s Disease
Open Access
- 29 August 2018
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-9
Abstract
Cinnamon extract has been reported to have positive effects in fruit fly and mouse models for Alzheimer’s disease (AD). However, cinnamon contains numerous potential active compounds that have not been individually evaluated. The main objective of this study was to evaluate the impact of cinnamaldehyde, a known putative active compound in cinnamon, on the lifespan and healthspan of Drosophila melanogaster models for Alzheimer’s disease, which overexpress Aβ42 and MAPT (Tau). We found that cinnamaldehyde significantly improved the lifespan of both AD and non-AD flies. Cinnamaldehyde also improved the healthspan of AD flies overexpressing the Tau protein by improving climbing ability, evaluated by rapid iterative negative geotaxis (RING), and improving short-term memory, evaluated by a courtship conditioning assay. Cinnamaldehyde had no positive impact on the healthspan of AD flies overexpressing the Aβ42 protein.Keywords
Funding Information
- University of California
This publication has 19 references indexed in Scilit:
- In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning StudyNeurotoxicity Research, 2018
- Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer’s Disease: A Comparison of the Cognitive and Clinical ProfilesJournal of Alzheimer’s Disease, 2017
- Extension of Drosophila lifespan by cinnamon through a sex-specific dependence on the insulin receptor substrate chicoExperimental Gerontology, 2014
- Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52Nature Communications, 2014
- Drosophila melanogaster as a model organism for Alzheimer’s diseaseMolecular Neurodegeneration, 2013
- Pharmaceutical applications and phytochemical profile of Cinnamomum burmanniiPharmacognosy Reviews, 2012
- Loss of motor function in preclinical Alzheimer’s diseaseExpert Review of Neurotherapeutics, 2011
- Orally Administrated Cinnamon Extract Reduces β-Amyloid Oligomerization and Corrects Cognitive Impairment in Alzheimer's Disease Animal ModelsPLOS ONE, 2011
- Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila : A potential model for Alzheimer's diseaseProceedings of the National Academy of Sciences, 2004
- Apolipoprotein E, ɛ4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal regionHuman Molecular Genetics, 1994